Uma unesifo segazi futhi ukhulelwe, udokotela wakho angancoma i-aspirin
Kungenzeka ukuthi ufunde ukuthi ukuthatha umthamo ophansi noma i-aspirin yengane ngenkathi ukhulelwe kungasiza ekunciphiseni ingozi yokuhlukumezeka. Kodwa-ke, inkolelo ngemuva kokuthatha i-aspirin ye-dose ephansi ngenkathi ukhulelwe yinkimbinkimbi encane.
Esinye sezizathu zokukhubazeka okuphindaphindiwe sine-disorder efana ne-antiphospholipid syndrome noma enye i-thrombophilia, uhlobo lwe-disorder yegazi olwandisa amathuba okugaya igazi.
Uma unesifo se-thrombophilia, unomkhuba okhulayo wokwenza ama-blood clots, okusho ukuthi ngemuva kokufaka egazini lakho kungenzeka ukuthi unamathele emithanjeni yegazi encane ye-placenta-mhlawumbe unqume ukuhlinzeka izakhi kumntwana.
I-aspirin isebenza njengegazi elincane, futhi igazi elincinci alikwazi ukugqoka. Izindleko eziphakeme kakhulu ze-aspirin (njengezibhebhe ongazithatha uma unesifo esibuhlungu) zingabangela izinkinga ekukhulelwe, kodwa abacwaningi bebelokhu bezama i-aspirin ye-dose ephansi noma i-aspirin yengane ukuze babone ukuthi ingakwazi yini ukuvimbela ukukhipha isisu, ikakhulukazi uma unesifo segazi.
Yini Antiphospholipid Syndrome?
I-Antiphospholipid syndrome yisifo esizimele esihilela ukukhiqizwa kwama-antibodies ahlasela amaprotheni ahlanganisa amaphospholipid esikhundleni se-phospholipids. Labo abane-antiphospholipid syndrome bahlakulele i-thrombophilia futhi bavale kalula.
Ukuthambekela okwenyuka kwe-clot kungabangela i-thrombosis yamasculazi kanye nokucindezeleka kokukhulelwa kanye nokucindezeleka okujulile okungaholela ekubambeni kwe-pulmonary. Abesifazane abane-antiphospholipid syndrome bavame ukuba nezimo eziphuthumayo eziphindaphindiwe.
I-Antiphospholipid syndrome ibhekwa njengesimo esibucayi kakhulu, uma unesifo se-antiphospholipid syndrome, kufanele ulawulwe ochwepheshe.
Lesi simo siphathwa nge-aspirin ne-heparin.
Abacwaningi abaqiniseki ukuthi yini ngempela eyenza i-antiphospholipid syndrome. Kodwa-ke, siyazi ukuthi i-antiphospholipid syndrome ijwayele ukugijima emindenini, futhi ngezinga elithile lofuzo, futhi ihlotshaniswa ne-HLA-DR4, i-DRw53, i-DR7 ne-C4 null allele.
Izinkinga ze-Thrombophilia Phakathi nokukhulelwa
Ucwaningo oluningi luye lwabheka i-aspirin ye-dose ephansi ngesikhathi sokukhulelwa, futhi kuvumelana ukuthi i-aspirin ephansi-dolobha noma amajojo we-heparin, elinye igazi elincane kakhulu, liba njengendlela yokwelashwa okuhle kwabesifazane abanenkinga yokuthola i-thrombophilia.
Ijaji lisekhona ukuthi ukuthatha i-aspirin ye-dose ephansi kungase kuzuze abesifazane abaye babhekana nokuhlukunyezwa okuphindaphindiwe kodwa abanalo i-thrombophilia disorder. Olunye ucwaningo luye lwahlola lo mbono futhi aluzuzanga nzuzo ekuthatheni i-aspirin ye-dose ephansi ngenkathi ezinye izifundo zithole ukuthi zingazuza. I-aspirin yengane ingase inzuze ezinye izinkinga zokukhulelwa , njengokunciphisa ukukhula komntwana noma ukukhulelwa kwengcindezi ephakeme yegazi, kodwa isiphetho asenzanga okwamanje.
I-aspirin ye-low-dose icatshangwa ukuthi iphephile ngisho nangesikhathi ukhulelwe, ngakho-ke udokotela wakho angancoma ukuthi uzame ukuthatha i-aspirin ye-dose ephansi uma uke wabhekana nokuhlukunyezwa okuphindaphindiwe.
Ngisho noma i-aspirin iyatholakala phezu kwe-counter, njalo uthola imvume yodokotela ngaphambi kokuthatha ingane aspirin ngesikhathi ukhulelwe. Qinisekisa ukuthi ukhuluma nganoma yimiphi imithi ongayithatha njengoba i-aspirin ingaxhumana neminye imithi futhi ingaba yingozi kubantu abanezinkinga ezithile zokuphuma kwegazi.
Imithombo
- Ilabhulali Kazwelonke Yezokwelapha. "Ukugonywa kanye ne-Chemoprophylaxis." I-HSTAT: Umhlahlandlela Wezinsizakalo Zokuvimbela Amitholampilo: I-Second Edition .
- Rai, R., H. Cohen, M Dave, noL. Regan. "Isivivinyo esilawulwe ngokungahleliwe se-aspirin ne-aspirin kanye ne-heparin kwabesifazane abakhulelwe abanezinsizwa eziphindaphindiwe ezihlobene ne-phospholipid antibodies (noma antibospholipid antibodies)." I-British Medical Journal 25 Jan 1997: 253-257.